Powered by

What's at stake for pharma in Pelosi's pricing plan? Megabillions—but there's reason not to panic

Sep 11, 2019 - FiercePharma

A leaked drug pricing plan sent some pharma investors running for the exits over the past two days, even as Congressional aides said the planwas outdatedandanalysts called it "unpassable."There's reason for the fear—but also reason to take the plan with several grains of salt.

Under House Speaker Nancy Pelosi's drug pricing plan that went public late Monday, Democrats would empower HHS to negotiate prices for thetop 250 drugswithout serious copycat competition. An international price ind...